NHL
Clinical trials for NHL explained in plain language.
Never miss a new study
Get alerted when new NHL trials appear
Sign up with your email to follow new studies for NHL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo aims to control blood cancer without chemotherapy
Disease control OngoingThis study is testing whether a combination of two drugs, copanlisib and rituximab, can effectively slow the growth of follicular lymphoma in people who haven't had treatment yet. The goal is to see if this drug pair can produce deep and lasting remissions without using tradition…
Matched conditions: NHL
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New hope for lymphoma patients at high risk of cancer returning
Disease control OngoingThis study tests whether adding the immunotherapy drug atezolizumab after standard chemotherapy can help prevent cancer from returning in patients with high-risk diffuse large B-cell lymphoma. The trial enrolled 109 adults who had responded well to initial treatment but remain at…
Matched conditions: NHL
Phase: PHASE2 • Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC